Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up

Once the first wave of SARS-CoV-2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy1. Symptoms persisting 3 - 6 months after acute COVID-19 (post-COVID syndrome) have been described 2,3,4,5. Currently, there is a lack of information on post-COVID consequences in elderly patients with asthma. Asthma in elderly is known to have specific features, such as high comorbidity, use of multiple pharmacological agents, individual response to treatment, different perception of the disease, and the highest mortality compared to other age groups6.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research